Does Belsomra (Suvorexant) Worsen Restless Leg Syndrome (RLS)?
Belsomra (suvorexant) should be avoided in patients with RLS as it may potentially worsen symptoms due to its antihistaminergic properties, which are known to exacerbate RLS.
Mechanism and Concerns
- The American Academy of Sleep Medicine specifically recommends addressing potential exacerbating factors for RLS, including antihistaminergic medications 1
- Belsomra (suvorexant) is an orexin receptor antagonist with antihistaminergic properties that could potentially worsen RLS symptoms 1
- Medications with antihistaminergic effects are known to exacerbate RLS and should be avoided in patients with this condition 1
Preferred Treatment Options for RLS
First-Line Treatments
- Alpha-2-delta ligands are strongly recommended as first-line therapy for RLS:
Iron Therapy
- Iron supplementation should be considered if serum ferritin ≤75 ng/mL or transferrin saturation <20% 1
- Options include:
Medications to Avoid in RLS
- Antihistaminergic medications (including suvorexant) should be avoided as they can exacerbate RLS symptoms 1
- Serotonergic medications should be avoided as they may worsen RLS 1
- Antidopaminergic medications should be avoided as they can worsen RLS 1
- The American Academy of Sleep Medicine specifically recommends against several medications for RLS treatment, including:
Managing RLS Symptoms
Non-pharmacological approaches that may help include:
For patients requiring medication for both sleep and RLS, consider:
Conclusion
When treating patients with both insomnia and RLS, it's important to select medications that won't exacerbate RLS symptoms. Belsomra (suvorexant) should be avoided in these patients due to its antihistaminergic properties. Instead, consider alpha-2-delta ligands which can address both conditions without worsening RLS symptoms.